Article Surfing Archive

Our body is the most complicated machinery which nature has ever created. There is a perfect coordination among all systems of the body. Nature has enabled human beings to accumulate fat beneath the skin which is there to provide them energy during hard days. This is because man came on the earth as a hunter and gatherer. With the development of his mind man has started modification of things around him according to his ease. Gradually, amount of physical activity was reduced and access to food increased. Due to this phenomenon more and more fat is accumulated in the body of those people who don't do sufficient physical work but intake excessive diet.

Obesity is an epidemic. What are the characteristics of any epidemic? There are generally three characteristics of an epidemic, it spreads rapidly; it affects a large population; it is fatal. Obesity has all these characteristics. People in all developed countries were already suffering from this disease, but now it has trapped many people in the countries of third world in its paws too. Today, millions across the globe are suffering from this disease. Moreover, obesity damages all vital and delicate internal organs badly. An obese is vulnerable to heart failure, brain stroke, kidney failure, gall bladder bursting, liver bursting, impotency, arthritis. All these are notorious for killing millions every year.

The simple principle to reduce obesity can be achieved by lowering down the excessive intake of calories and doing proper physical work. Both are hard to do in modern jet age. Where is the time for regular exercising? How can one reduce intake of calories when he or she is already taking food according to the need of the body. If you are facing such problems, then there is a way out for you. Appetite suppressant like Acomplia can help when you find it difficult to have a control over your diet.

Acomplia is the product launched by Sanofi-Aventis of France. This high efficacy appetite suppressant was launched in the UK anti-obesity drug market in the month of June. The drug is a ray of hope for million suffering from obesity. Acomplia has a chemical named Rimonabant which blocks the CB-1 receptor present in nerve cells. CB-1 receptor is the part of that mechanism which transmits hunger signals to the brain. Inhibiting working of CB-1 receptor means you will not feel enormous urge for food. In absence of food the metabolic system will burn the extra fats to get energy and an obese will get normal stature. Acomplia can also curb urge for smoking.

Using Rimonabant may have some mild initial side effects like nausea, constipation, stomach disorder and dizziness. Once the body is adjusted to the medication these problems disappear automatically. This is an oral prescription drug which must be taken on doctor's advice.

Acomplia's high efficacy in curbing dual problems i.e. obesity and smoking, therefore people are rushing for it. Sanofi-Aventis is planning to launch the drug in the US market after getting FDA approval for it.